189 related articles for article (PubMed ID: 21471518)
1. Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer.
Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
Cancer Genomics Proteomics; 2011; 8(2):87-92. PubMed ID: 21471518
[TBL] [Abstract][Full Text] [Related]
2. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
[TBL] [Abstract][Full Text] [Related]
4. Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer.
Nakao T; Iwata T; Hotchi M; Yoshikawa K; Higashijima J; Nishi M; Takasu C; Eto S; Teraoku H; Shimada M
Oncol Rep; 2015 Oct; 34(4):1961-7. PubMed ID: 26260776
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
[TBL] [Abstract][Full Text] [Related]
6. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
8. [A case report of locally advanced rectal carcinoma effectively treated with preoperative chemoradiotherapy].
Kitani K; Okajima K; Kimura H; Ikeda M; Inoue K; Iwama M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ishikawa K; Ota Y; Inoue M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2635-7. PubMed ID: 21224663
[TBL] [Abstract][Full Text] [Related]
9. Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Saito G; Miyakita H; Ogimi T; Nagase H
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1077-1085. PubMed ID: 28417167
[TBL] [Abstract][Full Text] [Related]
10. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
[TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
[TBL] [Abstract][Full Text] [Related]
12. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
[TBL] [Abstract][Full Text] [Related]
13. XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer.
Grimminger PP; Brabender J; Warnecke-Eberz U; Narumiya K; Wandhöfer C; Drebber U; Bollschweiler E; Hölscher AH; Metzger R; Vallböhmer D
J Surg Res; 2010 Nov; 164(1):e61-6. PubMed ID: 20863523
[TBL] [Abstract][Full Text] [Related]
14. Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.
Rimkus C; Friederichs J; Boulesteix AL; Theisen J; Mages J; Becker K; Nekarda H; Rosenberg R; Janssen KP; Siewert JR
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):53-61. PubMed ID: 18166477
[TBL] [Abstract][Full Text] [Related]
15. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
16. A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
Tanishima H; Horiuchi T; Tamagawa K; Tsujimoto T; Miyagawa Y; Ishida K; Uemura R; Hama T; Sakaguchi S; Shono Y; Tsubakihara H; Tabuse K
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1397-400. PubMed ID: 20647736
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profile is associated with chemoradiation resistance in rectal cancer.
Gantt GA; Chen Y; Dejulius K; Mace AG; Barnholtz-Sloan J; Kalady MF
Colorectal Dis; 2014 Jan; 16(1):57-66. PubMed ID: 24034224
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes.
Watanabe T; Kobunai T; Akiyoshi T; Matsuda K; Ishihara S; Nozawa K
Dis Colon Rectum; 2014 Jan; 57(1):23-31. PubMed ID: 24316942
[TBL] [Abstract][Full Text] [Related]
20. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles.
Watanabe T; Komuro Y; Kiyomatsu T; Kanazawa T; Kazama Y; Tanaka J; Tanaka T; Yamamoto Y; Shirane M; Muto T; Nagawa H
Cancer Res; 2006 Apr; 66(7):3370-4. PubMed ID: 16585155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]